Propensity-score matching enabled the comparison of 1,708 pairs who used GLP-1 receptor agonists or who did not
Daily targets: Sodium: 2,500-3,000mg with medical guidance Potassium: 4,700mg or more with medical monitoring Magnesium glycinate: 350mg supplemental (upper limit) Calcium citrate: 1,000-1,200mg supplemental (divided doses) Vitamin D: 2,000 IU daily Oral rehydration solution (ORS): As needed after each episode of fluid loss Implementation: Sip ORS continuously throughout the day Small frequent electrolyte doses rather than large single doses Bone broth as tolerated between meals Magnesium and calcium in divided doses to maximize absorption Daily symptom tracking including fluid intake, urine color, and episodes of vomiting or diarrhea Contact provider if unable to keep fluids down for more than 24 hours If you are on Protocol 3, talk to your healthcare provider about whether a dose adjustment is appropriate
To help you reach your goals, a Midi clinician will support you with advice on the lifestyle changes that are best for you
For gastrointestinal use, it is commonly discussed for gut irritation, gastritis-type symptoms, reflux-type irritation, inflammatory gut symptoms, and mucosal support
Acute gallbladder disease or gallstones severe pain in your upper stomach, yellowing of skin or eyes, fever, or clay-colored stool
( c ) Heatmaps and summary bar charts of metabolic gene expression patterns of genes from ( b )